22 May 2013
Keywords: novartis, submits, nda, fda, rasilez, swiss, drug
Article | 24 April 2006
Swiss drug major Novartis says that the US Food and Drug Administration has accepted its New Drug Application for Rasilez
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 April 2006
1 May 2006
21 May 2013
© 2013 thepharmaletter.com